25-08-2026 22:23 via medpagetoday.com

Monoclonal for Dengue Shows Promise in Hospitalized Cases

(MedPage Today) -- An investigational monoclonal antibody targeting dengue virus (Dengue-mAb) safely reduced viral loads and infection symptoms, according to a placebo-controlled phase II trial in India.
Among 249 adults hospitalized with dengue...
Read more »

Medical Industry news



First Drug OK'd for Warm Autoimmune Hemolytic Anemia
'Practice-Changing' Data Expand Zanidatamab's Approval to Gastroesophageal Cancer
More NFL Players Have CTE Than Previously Thought, Study Suggests
Trump Cuts Mask True Extent of Cyclospora Outbreaks
FDA Authorizes First Wearable Dual Glucose-Ketone Sensor
'Gray Market' Retatrutide Study; Menopause and the Brain; Drug Allergy Warnings
Controversial Neurologist to Lead NIH Unit; Hunter Trial Halted; Dads and Valproate
Dementia Drug Helpful With Lupus Brain Fog
Trump Administration Takes Second Swing at Hefty Fees for Visa Applicants
AI-Flagged PH & Pericarditis; Lagging Cardiology Workforce; Multi-Day Heart Rhythms
Clearing Out the Clutter, in Our Drawers and in Healthcare
U.S. Measles Deaths Reported
Florida, Hard-Hit by ACA Drop-Off, Feels the Squeeze of Rising Healthcare Costs
FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care
Desktop versie